1
|
Köpf I, Strid KG, Islam MQ, Granberg S, Friberg LG, Levan G, Carstensen J. Heterochromatin variants in 109 ovarian cancer patients and 192 healthy subjects. Hereditas 2008; 113:7-16. [PMID: 2272846 DOI: 10.1111/j.1601-5223.1990.tb00693.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Aberrations of the C-band region of chromosome no. 1 (1qh) were studied in 109 patients with ovarian cancer and 192 healthy subjects. The groups were compared for heterochromatin size variations, intrapair size asymmetry, and inversion. No significant correlation was found between the size of 1qh and ovarian cancer. Heterochromatin size asymmetry was estimated visually and determined by objective measurement of 1qh length or area; the methods show strong correlation. The measurements were normalised by comparison with the length or area of 16p or the entire chromosome no. 1. However, since good reliability was found by simply relating the 1qh size difference to the mean 1qh size, this was considered an appropriate and simpler method of normalisation. Asymmetry indices of length and area measurements correlated well, implying that the simpler method of length measurements can be readily used. 1qh asymmetry, measured objectively or estimated visually, was significantly increased in the cancer patient group. The incidence of C-band inversion was significantly increased in the patient group. Moreover, inversion increased significantly with increasing 1qh asymmetry.
Collapse
Affiliation(s)
- I Köpf
- Department of Oncology, University of Göteborg, Sweden
| | | | | | | | | | | | | |
Collapse
|
2
|
Köpf I, Islam MQ, Friberg LG, Levan G. Familial occurrence of cancer and heteromorphism of the heterochromatic segment of chromosome 1. Hereditas 2008; 110:79-83. [PMID: 2777631 DOI: 10.1111/j.1601-5223.1989.tb00421.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
During the last decade, evidence has been forthcoming in support of the correlation between heteromorphism of human chromosome 1qh and the incidence of various malignancies in the carriers of such heteromorphism. We present data from a family with hereditary predisposition to cancer. In this family, five members in a sibship of seven developed ovary and/or colon carcinoma at comparatively young ages. A further 4 cases of malignant disease were ascertained, when a pedigree of 36 family members of 3 generations was constructed. Chromosome analysis was carried out in G- and C-banding from peripheral blood cultures of 19 family members. Distinct heteromorphism in the chromosome 1qh region was detected in 15 (79%) of them, including all 3 cancer patients investigated.
Collapse
|
3
|
Kristoffersson U, Bernheim A, Berger R, Nilsson B, Heim S, Mandahl N, Mitelman F. Constitutional C-band polymorphism in lymphocytes from patients with chronic myeloid leukemia. Hereditas 2008; 110:145-8. [PMID: 2745151 DOI: 10.1111/j.1601-5223.1989.tb00434.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
The C-band heterochromatin polymorphism of chromosomes 1, 9, and 16 was studied in lymphocytes from 53 patients with Ph1-positive chronic myeloid leukemia (CML) and 183 control persons. The patients had significantly larger heterochromatic blocks on chromosome 16 (p less than 0.01) and fewer partial inversions of chromosome 9 (p less than 0.05) than the control persons, whereas no differences were found for the symmetry/asymmetry pattern. We suggest that the increased constitutive heterochromatin regions may, via sister chromosome exchange, facilitate homo- or hemizygotization of genes which favor neoplasia development and/or progression.
Collapse
MESH Headings
- Chromosome Aberrations
- Chromosome Banding
- Chromosome Inversion
- Chromosomes, Human, Pair 1/ultrastructure
- Chromosomes, Human, Pair 16/ultrastructure
- Chromosomes, Human, Pair 9/ultrastructure
- Heterochromatin/ultrastructure
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics
- Polymorphism, Genetic
- Sister Chromatid Exchange
Collapse
|
4
|
Sivakumaran TA, Ghose S, Kumar H, Singha U, Kucheria K. Absence of pericentromeric heterochromatin (9qh-) in a patient with bilateral retinoblastoma. ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE 1998; 46:193-8. [PMID: 9862007 DOI: 10.1017/s0001566000000428] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The polymorphisms of constitutive heterochromatin regions, present on chromosomes 1, 9, 16 and Y, are inherited in a Mendelian fashion. The C-band heteromorphism has been reported to be associated with various types of cancer. Heterochromatin is considered to play a role in protecting genome against the mutagens. Changes in the quantity and proportion of the different types of satellite DNA might increase the genetic susceptibility in people with heterochromatic variations, which in turn cause chromosome instability and predispose the individual to cancer. We report a case of bilateral retinoblastoma with complete absence of pericentromeric heterochromatin on one of the chromosomes number 9. A similar deficiency of pericentromeric heterochromatin on chromosome number 9 and 16 has been reported in a phenotypically normal individual and a Down syndrome case, respectively. This deficiency was found to be inherited from the father in all the three cases. Complete absence of pericentromeric heterochromatin of chromosome 9 is not being reported in association with cancer syndromes. Further studies are necessary to understand the role of this factor in normals and in those with cancer susceptibility, specially with retinoblastoma and the paternal origin of this deficiency.
Collapse
Affiliation(s)
- T A Sivakumaran
- Department of Anatomy, Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India of Medical Sciences, New Delhi, India
| | | | | | | | | |
Collapse
|
5
|
Schmidt HH, Sill H, Eibl M, Beham-Schmid C, Höfler G, Haas OA, Krejs GJ, Linkesch W. Hodgkin's disease developing after spontaneous remission of chronic lymphocytic leukemia. Ann Hematol 1995; 71:247-52. [PMID: 7492627 DOI: 10.1007/bf01744374] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
We present a 71-year-old patient with chronic lymphocytic leukemia diagnosed 27 years ago. Initially, the disease was staged as Rai II and the patient suffered from secondary immunoglobulin deficiency. Nevertheless, no treatment was necessary at that time. Because of disease progression a single course of chemotherapy was given in 1984. During the following year there was a constant decline of the WBC, accompanied by normalization of the immunoglobulins; both have remained stable ever since that time. However, there was still residual bone marrow infiltration, indicating persisting CLL. In 1993 cervical lymphadenopathy occurred with acute onset. A diagnostic lymphadenectomy revealed Hodgkin's disease of the nodular-sclerosing subtype. The patient was staged as II-III according to the Ann Arbor Classification and underwent radiation therapy. Cytogenetic examination of the bone marrow revealed a normal karyotype with an inversion of chromosome 9. This case demonstrates the rate coincidence of two lymphoproliferative disorders in the same patient. The clinical course and the immunologic findings of this patient are presented, together with a review of the literature.
Collapse
MESH Headings
- Adult
- Bone Marrow/pathology
- Chromosome Inversion
- Chromosomes, Human, Pair 9
- Female
- Hodgkin Disease/genetics
- Hodgkin Disease/pathology
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell/genetics
- Leukemia, Lymphocytic, Chronic, B-Cell/pathology
- Neoplasm Staging
- Neoplasms, Second Primary
- Remission, Spontaneous
Collapse
Affiliation(s)
- H H Schmidt
- Department of Internal Medicine, University of Graz, Austria
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Islam MQ, Köpf I, Levan A, Granberg S, Friberg LG, Levan G. Cytogenetic findings in 111 ovarian cancer patients: therapy-related chromosome aberrations and heterochromatic variants. CANCER GENETICS AND CYTOGENETICS 1993; 65:35-46. [PMID: 8431914 DOI: 10.1016/0165-4608(93)90056-r] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The chromosomes of 111 ovarian cancer patients were studied in G- and C-banded slides from peripheral blood lymphocyte (PBL) cultures for chromosome damage caused by chemotherapy and radiotherapy and for asymmetry of the constitutive heterochromatin of chromosomes 1, 9, and 16. We also monitored the survival of these patients to determine whether any secondary neoplasia induced by the therapy and report the findings of our investigations. Melphalan (MEL) was the only drug used in single-drug chemotherapy. The incidence of chromosome abnormalities in melphalan-treated cells (25%) was higher than in the control group (17%). The incidence of structural changes was also higher (10.5%) in the MEL-treated group than in controls (6%). After treatments with combinations of drugs, the incidence of structural changes remained at the same level (11%). In the patients receiving combined treatment with MEL and radiation, the rate of structural changes increased dramatically (24%). The overall rate of chromosome aberrations in this group was also higher (50%). Combination of two or more drugs and radiation produced only 14% structural chromosome changes. The overall rate of chromosome aberrations was also low (20%) in this group. Of 111 patients studied, only 33 were alive 6 years after initiation of the study. Of the surviving patients, eight had rearranged chromosomes in the first analysis. After 5 years, new blood samples were collected from these patients and chromosome analyses showed abnormal karyotypes in all eight patients. All chromosome abnormalities in the second analysis were completely unrelated to those in the first analysis, however. Whether the chromosome changes in the second analysis were due to therapy or to other unknown factors could not be determined. Data on C-banding and the distribution of inversions indicated that 91% of the patients had C-band heteromorphisms of chromosomes 1, 91% had heteromorphisms of chromosome 9, and 69% had heteromorphisms of chromosome 16. Furthermore, inversions were observed in chromosome 1 (41% of patients), chromosome 9 (28% of patients), and chromosome 16 (5% of patients).
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Antineoplastic Agents/adverse effects
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Child
- Chromosome Aberrations
- Chromosome Deletion
- Chromosome Inversion
- Chromosomes, Human, Pair 16/drug effects
- Chromosomes, Human, Pair 16/radiation effects
- Chromosomes, Human, Pair 9/drug effects
- Chromosomes, Human, Pair 9/radiation effects
- Cisplatin/adverse effects
- Combined Modality Therapy/adverse effects
- Cyclophosphamide/adverse effects
- Doxorubicin/adverse effects
- Female
- Fluorouracil/adverse effects
- Follow-Up Studies
- Heterochromatin/drug effects
- Heterochromatin/radiation effects
- Humans
- Karyotyping
- Melphalan/adverse effects
- Methotrexate/adverse effects
- Middle Aged
- Mitomycins/adverse effects
- Neoplasms, Second Primary/etiology
- Ovarian Neoplasms/drug therapy
- Ovarian Neoplasms/genetics
- Ovarian Neoplasms/radiotherapy
- Radiotherapy/adverse effects
- Translocation, Genetic
- Vincristine/adverse effects
Collapse
Affiliation(s)
- M Q Islam
- Department of Genetics, University of Gothenburg, Sweden
| | | | | | | | | | | |
Collapse
|
7
|
Tsezou A, Kitsiou-Tzeli S, Kosmidis H, Paidousi K, Katsouyanni K, Sinaniotis C. Constitutive heterochromatin polymorphisms in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1993; 10:7-11. [PMID: 8443055 DOI: 10.3109/08880019309016522] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The C-band heterochromatin polymorphisms of chromosomes 1, 9, and 16 were studied on peripheral lymphocytes of 67 children with acute lymphoblastic leukemia (ALL) and 50 control individuals. A statistically significant difference between patients and controls was found for large heterochromatin regions (level 3) of chromosomes 1 and 9 (P < 0.001) and for small heterochromatin regions (level 1) of chromosome 16 (P < 0.001). The patients also showed a significant increase in chromosomes 1 and 9 heteromorphism with respect to controls (P < 0.001).
Collapse
Affiliation(s)
- A Tsezou
- 2nd Department of Pediatrics, University of Athens, P & A Kyriakou Children's Hospital, Greece
| | | | | | | | | | | |
Collapse
|
8
|
Petković I, Nakić M, Konja J. Heterochromatic variability in children with acute lymphoblastic leukemia. CANCER GENETICS AND CYTOGENETICS 1991; 54:67-9. [PMID: 2065317 DOI: 10.1016/0165-4608(91)90031-o] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
An analysis of the C-segment variability of chromosomes 1, 9, and 16 was carried out in 38 children with ALL, and 90 control subjects. When studying location variants, no differences were found between group of patients and the normal controls. A larger quantity of structural heterochromatin was, however, observed on chromosomes 1, 9, and 16, and a higher frequency of homologous chromosomes heteromorphism in children with ALL when compared with the control group.
Collapse
Affiliation(s)
- I Petković
- Zagreb Department of Pediatrics Faculty of Medicine, University of Zagreb, Yugoslavia
| | | | | |
Collapse
|
9
|
Dave BJ, Trivedi AH, Adhvaryu SG. Variations in centromeric heterochromatin among patients with pre-malignant and malignant oral diseases. Int J Cancer 1991; 48:386-9. [PMID: 2040533 DOI: 10.1002/ijc.2910480313] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Polymorphism of heterochromatic regions of chromosomes 1, 9 and 16 was studied in 60 oral cancer patients, in 40 patients with oral submucous fibrosis (OSMF) and in 60 normal healthy subjects. The size heteromorphism was significantly greater (p less than 0.001) in chromosome I of the patients. Localization variants were also significantly more frequent among the patients (p less than 0.05 for OSMF and less than 0.001 for oral cancer patients). The C-band heteromorphism patterns remained comparable in OSMF and in oral cancer patients, with chromosome I being the most frequently involved. On correlating the tobacco/areca-nut chewing habit with the presence of C-band heteromorphism, we observed that C-band heteromorphism was present in 89% of the habit-free oral cancer patients and 80% of the OSMF patients with relatively shorter exposure to this habit, i.e. less than 5 years. This signifies that genetic factors are important in the causation of oral precancerous and cancerous conditions and that polymorphism of the heterochromatic regions does appear to play a role in these conditions.
Collapse
MESH Headings
- Adult
- Areca
- Carcinoma, Squamous Cell/genetics
- Carcinoma, Squamous Cell/pathology
- Centromere/ultrastructure
- Chromosome Banding
- Chromosomes, Human, Pair 1
- Chromosomes, Human, Pair 16
- Chromosomes, Human, Pair 9
- Female
- Genetic Variation
- Heterochromatin/ultrastructure
- Humans
- Male
- Mouth Diseases/genetics
- Mouth Diseases/pathology
- Plants, Medicinal
- Polymorphism, Genetic
- Precancerous Conditions/genetics
- Precancerous Conditions/pathology
- Reference Values
- Smoking
Collapse
Affiliation(s)
- B J Dave
- Cell Biology Division, Gujarat Cancer and Research Institute, Ahmedabad, India
| | | | | |
Collapse
|
10
|
Lundgren R, Berger R, Kristoffersson U. Constitutive heterochromatin C-band polymorphism in prostatic cancer. CANCER GENETICS AND CYTOGENETICS 1991; 51:57-62. [PMID: 1984847 DOI: 10.1016/0165-4608(91)90008-i] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The size of the heterochromatin C-bands on chromosomes has been reported to be associated with some, but by no means all, human malignancies. No studies along these lines have been performed in prostatic cancer. We therefore investigated the size, incidence of inversions, and symmetry versus asymmetry of C-band heteromorphisms on chromosomes 1, 9, and 16 in peripheral blood lymphocytes from 52 prostatic cancer patients and 183 healthy individuals. There were no differences in C-band heteromorphism on chromosomes 1, 9, and 16 between the patients and the controls. Neither were there any differences when patients with early-stage disease were compared with patients with more advanced cancer. Younger (aged less than 70 years) cancer patients had significantly higher frequencies of larger C-bands on chromosomes 1 (p less than 0.01) and 16 (p less than 0.001) than did patients aged more than 70 years at diagnosis. This could indicate a possible relationship between the amount of constitutive heterochromatin on chromosomes 1 and 16 and susceptibility to early development of prostatic cancer but could also result from the age differences between the two patient groups.
Collapse
Affiliation(s)
- R Lundgren
- Department of Urology, University Hospital, Lund, Sweden
| | | | | |
Collapse
|
11
|
Adhvaryu SG, Dave BJ, Trivedi AH, Rawal UM, Jani KH. Variability of Euchromatic and Heterochromatic Regions of Y Chromosome in Two Types of Cancer Patients. TUMORI JOURNAL 1989; 75:547-9. [PMID: 2617700 DOI: 10.1177/030089168907500606] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Heteromorphism of Y chromosome was studied in head and neck cancer patients and leukemia patients. The results were compared with similar data obtained for healthy men. It was observed that, compared to the controls, mean lengths of Y chromosome were nonsignificantly higher for leukemia patients and lower for head and neck cancer patients. The euchromatic region of Y chromosome (Y-eu) remained comparable in the controls and the leukemia patients, whereas it was smaller in patients with head and neck malignancies. The heterochromatic region (Y-het) was more or less analogous in controls and head and neck cancer patients, however, it was significantly larger in patients with leukemia (P < 0.02).
Collapse
Affiliation(s)
- S G Adhvaryu
- Cell Biology Division, Gujarat Cancer and Research Institute, Ahmedabad, India
| | | | | | | | | |
Collapse
|
12
|
Sampaio DA, Mattevi MS, Cavalli IJ, Erdtmann B. Densitometric measurements of C bands of chromosomes 1, 9, 16, and Y in leukemic and preleukemic disorders. CANCER GENETICS AND CYTOGENETICS 1989; 41:71-8. [PMID: 2766253 DOI: 10.1016/0165-4608(89)90109-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Fifty-six patients with blood disorders (23 with chronic myeloid leukemia, 14 with acute myeloblastic leukemia, seven with acute lymphoblastic leukemia, one with chronic lymphocytic leukemia, and 11 with preleukemia states) were studied. A quantitative and objective method of C band length analysis with well-matched controls was used. The C bands of chromosome pairs 1, 9, and 16 presented a normal distribution that was similar in patients and controls, whereas the Y chromosome presented an abnormal distribution. Smaller C bands in 1qh and higher indexes of intrapair heteromorphism in pairs 1 and 9 were detected in the CML group; the group of acute leukemias (myeloblastic and lymphoblastic) presented a smaller index only in pair 1qh. No other differences in length, heteromorphism, inversion frequency, or sex were detected.
Collapse
Affiliation(s)
- D A Sampaio
- Centro de Hematologia e Hemoterapia de Pernambuco, Recife, Brazil
| | | | | | | |
Collapse
|